Floatz logo

10 assets in Differentiated Thyroid Carcinoma

Therapeutic assets addressing Differentiated Thyroid Carcinoma, rated under Floatz methodology v0.2 and sorted by current rating.

AssetSponsorPhaseRating
Cabozantinib
Differentiated Thyroid Carcinoma
ExelixisP3BB (66)
Atezolizumab
Differentiated Thyroid Carcinoma
ExelixisP3BB (64)
Nivolumab
Differentiated Thyroid Carcinoma
ExelixisP3BB (64)
Abiraterone
Differentiated Thyroid Carcinoma
ExelixisP3B (60)
Enzalutamide
Differentiated Thyroid Carcinoma
ExelixisP3B (60)
Prednisone
Differentiated Thyroid Carcinoma
ExelixisP3B (60)
Zanzalintinib
Differentiated Thyroid Carcinoma
ExelixisP3B (60)
Claturafenib
Differentiated Thyroid Carcinoma
PfizerP1CC (43)
pf-07799544
Differentiated Thyroid Carcinoma
PfizerP1CC (43)
Acc-1898
Differentiated Thyroid Carcinoma
AccSalus Biosciences, Inc.P1NR ()